About the Job
The internship will focus on our in vitro diagnostics development work in endometriosis and will involve the following responsibilities: writing research grant proposals, developing project plans, supporting the design and prototyping of our IVD assay, creating technical and scientific documents, defining processes within the product development cycle, outreach to clinical and industry partners to establish international collaborations.
We will provide training in quality management, clinical discovery and product development. The intern will be given the opportunity to work on diverse tasks that have a real impact on healthcare. We offer a hybrid work setup (combination of office-based and remote work).
We are looking for self-motivated, creative and independent people who are keen to see the immediate impact of their work and bring their ideas to life. If you are excited by the possibility of being part of a young startup and making an impact on healthcare, please send your application now!
Required skills and experience:
- excellent writing and presenting skills
- process-oriented
- interest in building relationships
- very good interpersonal skills
- self-motivated, flexible
- Very good English (oral & written)
- German would be an asset
- Master’s degree or PhD in Life Sciences or Engineering
- Allowed to work in Switzerland (Swiss/EU citizen and/or having a valid work permit)
Please send your application, including your cover letter and your CV (in English) to careers@scailyte.com
Call for applications open until Jul 31st, 2022
Starting date: 15th August, 2022
About Scailyte
Scailyte is a globally recognized spin-off from ETH Zürich and pioneer in the field of single-cell data analysis (Nature Spinoff Award, Forbes Top30 in AI, Masschallenge winner, Swiss Top100 Startups). Scailyte’s mission is to discover and develop biomarkers for precision medicine using single-cell data and Artificial Intelligence. Our pioneering technology integrates multimodal single-cell and clinical data to identify novel disease signatures. We are providing innovative solutions for rapid discovery of ultra-sensitive biomarkers for customers in pharma, biotech and clinical research. We are a multidisciplinary multinational team of highly skilled and enthusiastic professionals, offering an inspiring and open-minded environment for career growth. Check out our company video and what our employees say about working at Scailyte: Scailyte Youtube channel.
Recent News
Scailyte and Visterra Partner to Advance Autoimmune Disease Research
Scailyte AG, an AI-driven biomarker discovery company, and Visterra, Inc., a clinical-stage biopharm...
Recent News
Precision Medicine and The Future of Genomics Summit 2024
Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...
Recent News
Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution
In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...
Recent News
Recent News
Pitch Nic 2024 at Novartis Campus
We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...
Recent News
Genomics for Health 2024
Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...
Recent News
The Year of the AI Nobel
2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...
Recent News
Life Science Industry Meets Data Science Symposium
Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...
Recent News
Scailyte and Visterra Partner to Advance Autoimmune Disease Research
Scailyte AG, an AI-driven biomarker discovery company, and Visterra, Inc., a clinical-stage biopharm...
Precision Medicine and The Future of Genomics Summit 2024
Scailyte at the Global Stage of Precision Medicine – PMFG 2024! We are proud to share that our CEO...
Recent News
Exploring Type 2 T Cell Immunity in Cancer—A Single-Cell Revolution
In this issue of ScaiDigest, we highlight two groundbreaking studies that expand the boundaries of i...
Recent News
Pitch Nic 2024 at Novartis Campus
We’re thrilled to announce that our CEO, Peter Nestorov will join the innovative minds at Pitch Ni...
Genomics for Health 2024
Don't miss Scailyte's CEO, Peter Nestorov, at the Genomics for Health 2024 event, bridging cutting-e...
Recent News
The Year of the AI Nobel
2024 is being hailed as the "Year of the AI Nobel," marking a milestone as artificial intelligence (...
Life Science Industry Meets Data Science Symposium
Scailyte is thrilled to be part of the LIFE SCIENCE INDUSTRY MEETS DATA SCIENCE symposium organised ...